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A New Method to Quantify Aortic Biomechanics In
Vivo Using Four-Dimensional Magnetic Resonance
Imaging (4D MRI): Implications for Ascending
Aortic Endografts
Rachel Clough, Christian Buerger, Christoph Kolbitsch,
Peter Taylor, Claudia Prieto, Tobias Schaeffter. NIHR
Comprehensive Biomedical Research Centre of Guy’s
and St Thomas’ NHS Foundation Trust and King’s
College London, London, United Kingdom
Objectives: The thoracic aorta is subject to physiolog-
ical forces from cardiac and respiratory motion which have
an important effect on endograft failure such as fracture,
migration and endoleak. This study’s aim was to develop
newmethodology to accuratelymeasure aortic biomechanics
in vivo using 4D MRI and image registration techniques.
Methods: These consisted of: 1.Development of 4D
MRI acquisition schemes; 2.Optimization of non-rigid
image registration algorithm and assessment of accuracy
(TRE); 3.Quantiﬁcation of aortic biomechanics in vivo.
Results: High spatial resolution 4D dynamic imaging
sequences were developed to separately determine the
displacement of the aorta caused by cardiac and respiratory
motion. The registration algorithm was accurate [TRE-
cardiac: 2.05 6 1.27 mm; TRE-respiratory: 1.60 6 0.88
mm] and robust to changes in registration parameters.
The biomechanical displacement of the ascending aorta
(6.41 6 1.87 mm) was signiﬁcantly greater than the arch
(3.75 6 0.79 mm) (P < .0001(95%CI 1.7-3.6)) and
descending aorta (3.64 6 0.87 mm) (P < .0001(95%CI
1.8-3.7)). The motion of the arch was not signiﬁcantly
different to the descending aorta (P ¼ .68 (95%CI-0.4-
0.6)). The maximum displacement caused by cardiac and
respiratory motion was 16.9 mm and 7.7 mm respectively.
Signiﬁcant inter-individual differences in aortic deformation
and dynamic curvature were seen. Maximal displacements
occurred at peak systole in the ascending aorta and arch
whereas in the descending thoracic aorta there was minimal
change with time. In the ascending aorta there was a large
rotational component, demonstrated by large RL (4.71 6
0.52 mm) and AP displacements (2.65 6 0.76 mm).
Conclusions: We have successfully developed, vali-
dated and applied a new method to quantify aortic biome-
chanics in vivo. The motion of the ascending aorta is
complex, multidirectional and signiﬁcantly greater than
the arch and descending aorta. These data will inform
ascending aortic endograft design and advance durability
and deployment accuracy.
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Post-Discharge Outcomes After Endovascular
Abdominal Aortic Aneurysm Repair
Prateek K. Gupta1, Travis L. Engelbert1, Bala Ramanan2,
Xiang Fang2, Dai Yamanouchi1, John R. Hoch1, CharlesW. Acher1. 1Surgery, University of Wisconsin Hospital
and Clinics, Madison, Wisc; 2Creighton University,
Omaha, Neb
Objectives: Outcome improvement in the ﬁeld of
aortic surgery, speciﬁcally endovascular repair (EVAR) of
abdominal aortic aneurysms (AAA), has received much
attention. The focus, however, has been on inpatient
outcomes. With EVAR, the index hospital stay after aortic
surgery has decreased signiﬁcantly, leaving a need for better
understanding of post-discharge outcomes, which is neces-
sary to improve quality and reduce readmission rates with
proper targeted outpatient interventions. The objective of
this study was to examine post-discharge 30-day outcomes
after elective EVAR.
Methods: Patients who underwent an elective EVAR
for AAA (n ¼ 11,229) were identiﬁed from the ACS’
2005-10 NSQIP database. Univariable and multivariable
logistic regression analyses were performed.
Results: The median age for the patient cohort was
75 years with 82.7% males. The median (interquartile
range [IQR]) length of hospital stay was 2 (1-3) days.
Overall 30-day mortality rate was 1.0% (n ¼ 117),
with 31% (n ¼ 36) of the patients dying after discharge.
Overall 30-day morbidity rate was 10.7% (n ¼ 1204),
with 37.9% (n ¼ 456) of the morbidities being post-
discharge. The median time of death and complication
was 9 and 3 days, respectively, after surgery. Eighty-
one percent of the wound infections (n ¼ 190/234),
28% of pneumonia (n ¼ 37/133), and 51% of DVT (n
¼ 27/53) were post-discharge. On multivariable anal-
yses, age, dependent functional status, postoperative
pneumonia, and postoperative renal failure were inde-
pendently associated with post-discharge mortality, and
female gender and diabetes with post-discharge
morbidity (P < .05 for all).
Conclusions: A third of deaths and complications
after EVAR are post-discharge. Improved pre-discharge
surveillance and close post-discharge follow-up of identi-
ﬁed high-risk patients may further improve 30-day
outcomes after EVAR. Post-discharge interventions are
needed and should focus on complications with high rates
of occurrence after the index hospitalization.
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A Propensity-Matched Comparison of Fenestrated
EVAR and Open Surgical Repair of Complex
Abdominal Aortic Aneurysms
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Objectives: The beneﬁt of fenestrated EVAR
(FEVAR) to open surgery repair (OR) of complex
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study compares 30-day outcomes of these procedures
from two high volume centers, where FEVAR was under-
taken for “high risk” patients.
Methods: Patients undergoing commercially available
FEVAR and OR of CAAA (total suprarenal/visceral clamp
position) were propensity matched to identify demo-
graphic/clinical and anatomically similar cohorts. Peri-
operative outcomes were evaluated using univariate and
multivariate methods.
Results: From 7/01-8/12 59 FEVAR and 324 OR
patients were identiﬁed. Following (1:4) propensity match-
ing for age, gender, hypertension, CHF, CAD, COPD,
CVA, diabetes, preoperative creatinine and anticipated/
actual aortic clamp site, the study cohort consisted of 42
FEVAR and 147 open repairs. The most frequent FEVAR
construct was 2 renal fenestrations +/ single mesenteric
scallop in 50% of cases. Univariate analysis demonstrated
FEVAR had a higher 30 day mortality (8.7% vs 2%; P ¼
.05), any complication (41% vs 23%; P ¼ .01), procedural
complication (24% vs 7%; P < .01), and graft complication
(30% vs 2%; P < .01). Multivariate analysis identiﬁed
FEVAR had an increased 30 day mortality (OR, 5.1; 95%
CI, 1.1-24; P ¼ .04), risk of any complication (OR, 2.3;
95% CI, 1.1-4.9; P ¼ .01), and graft complication (OR,
24; 95% CI, 4.8-66; P < .01).
Conclusions: FEVAR, in this two center study, is
associated with a signiﬁcantly higher risk of peri-operative
mortality and morbidity than OR in CAAA. These data
suggest that extension of the paradigm comparing EVAR
to OR for routine AAA, to patients with CAAA is not
appropriate. Studies should ﬁrst establish proper patient
selection for FEVAR over OR before widespread use
should be considered.
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Video Presentation
Two-VesselFenestrationofGoreC3ExcluderEndograft
for Treatment of AAA in a High-Risk Patient With
Unfavorable Anatomy for Conventional EVAR
Amy Coulter, Tze-Woei Tan, Wayne W. Zhang. LSU
Health Sciences Center Shreveport, Shreveport, LA
Background: High risk patientswithAAA and anatomy
not suited for conventional endovascular repair have limited
options for treatment. The Gore Excluder endograft can
be reconstrained after deployment with the development
of the C3 delivery system and now can be utilized for
physician-modiﬁed fenestrated endovascular repair.
Technical Description: 1. Preoperative planning for
fenestration of a Gore C3 Excluder aortic endograft
using 3D reconstruction of a CT angiogram. A clock-
face orientation is used. 2. A 20F sheath is loaded ontothe delivery catheter for the aortic endograft. 3. The
endograft is partially deployed in a sterile fashion on
a back table. 4. The location of the fenestrations are
measured and marked. Fenestrations should be cut to
precisely the size of the renal artery oriﬁces or slightly
smaller. 5. The fenestrations are made. This was initially
attempted with an aortic punch, however it was much
simpler to simply cut the PTFE sharply. Wire-cutters
may be needed to cut any stent struts which impinge
on the fenestrations. 6. Radio-opaque snare wires are
sutured around the fenestrations and additional markers
are sutured to the endograft for orientation. 7. The
fenestrations are precannulated with 0.014 wires. 8.
The endograft is reconstrained using silk ties and umbil-
ical tape and loaded into the 20F sheath on the delivery
catheter. A Freer elevator is helpful in loading the supe-
rior portion of the main body which has metal anchors
which project out from the endograft. 9. The renal
arteries and SMA are identiﬁed with angiography. 10.
The main body is advanced to the level of the SMA
and the renal arteries are cannulated through the fenes-
trations with the 0.014 wires. The wires are then
exchanged for stiff wires and 6F guiding sheaths are
placed in the renal arteries. 11. The main body is
deployed. 12. Covered stent-grafts are deployed in the
renal arteries and ﬂared into the aortic endograft. 13.
The remainder of the procedure is ﬁnished in a conven-
tional fashion.
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Aortic Remodeling After Endovascular Treatment of
Complicated Type B Aortic Dissection Using
a Composite Device Design: A Report from the
STABLE Trial
Joseph V. Lombardi1, Richard P. Cambria2, Christoph
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Objectives: We report aortic remodeling from the
STABLE trial, a prospective, multicenter study evaluating
safety and effectiveness of a pathology-speciﬁc endovascular
system (proximal stent-graft and distal bare metal stent) for
the treatment of complicated type B aortic dissection
(cTBAD).
Methods: All 86 enrolled patients (mean age 59 years;
73% male) were treated within 90 days of symptom onset
(64% treated within 14 days). Aortic remodeling through
2 years was assessed in patients with available aortic size
data (as of April 2012).
